Revvity price target raised to $141 from $130 at TD Cowen

TD Cowen raised the firm’s price target on Revvity to $141 from $130 and keeps a Buy rating on the shares. The firm said they posted a good 2Q and guidance raise where despite headwinds on its large Reagent segment, the company was able to drive upside.